Dr. Momar Ndao’s Parasitology Laboratory

Bringing Neglected Tropical Diseases into the Spotlight
Research Associate Asieh Rasoolizadeh uses top-down analytical proteomics to pinpoint clinically relevant biomarkers of a variety of infectious diseases.  Her work with Dr. Ndao aims to improve methods of diagnosis, treatment and vaccination against neglected tropical diseases.

Dr. Ciriaco Piccirillo’s Laboratory of Immune Regulation

Pushing the Limits of Immune Characterization with a Single Drop of Blood  
Tho-Alfakar Al-Aubodah and Dr. Piccirillo’s team use various mouse and human models of disease to study how regulatory T cells control immune responses, and determine whether deficiencies in these cells underlie immunoregulatory defects in pathologic immune responses.

Dr. Nicole Bernard’s Immunology Laboratory

Unraveling the Mechanisms of HIV Resistance
Research Technician Tsoarello Mabanga uses Human Leukocyte Antigen (HLA) genotyping to identify unique immunological signatures implicated in the viral control seen in a rare subset of HIV Infected Elite Controllers, and in resistance to HIV infection.

Dr. Constantin Polychronakos’ Laboratory of Endocrine Genetics

Decoding a Genetic Link to Type I Diabetes
PhD student Meihang Li uses genetics and various immunological approaches to explain how specific genetic mutations could increase susceptibility to type I diabetes.



Proteomics and Drug Discovery Platforms of the RI-MUHC

Advancing how we Understand, Treat and Cure Diseases
Research Associate Ed Daily and Research Assistant Elizabeth-Ann Kranjec from the RI-MUHC Proteomics and Drug Discovery Platforms respectively, use state-of-the-art technologies to support researchers and facilitate the discovery of life-saving therapeutics.

Welcome to the McGill Interdisciplinary Initiative in Infection and Immunity

Leveraging the power of translational research for the prevention, cure and elimination of major infectious threats to human health in the 21st century.